Drugs / AJA001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06019065 | Sep 2023 → Mar 2024 | — | AJNA Australia Pty Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AJA001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06019065 ↗ |
| Route | Oral | “AJA001 active q.d. 2.2 mL oral dose level 1” NCT06019065 ↗ |